The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Squinto Stephen P since year 2005.
The trader's CIK number is 1231954.
At the time of this reporting, Squinto Stephen P is the EVP & Head of Research & Devel of Alexion Pharmaceuticals Inc .
(stock ticker symbol ALXN).
See this page for all insider trading activities at Alexion Pharmaceuticals Inc .
Stock purchases, sales, and option exercises reported by insider Squinto Stephen P since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-07-10
ALXN
Alexion Pharmaceuticals Inc
Sale
159
75.75
12,044
2008-05-19
ALXN
Alexion Pharmaceuticals Inc
Option Exercise
35,827
17.87
640,183
2008-05-19
ALXN
Alexion Pharmaceuticals Inc
Sale
35,827
69.81
2,500,993
2008-03-10
ALXN
Alexion Pharmaceuticals Inc
Sale
159
56.05
8,911
2008-01-10
ALXN
Alexion Pharmaceuticals Inc
Sale
712
69.02
49,142
2007-11-05
ALXN
Alexion Pharmaceuticals Inc
Option Exercise
33,465
21.00
702,765
2007-11-05
ALXN
Alexion Pharmaceuticals Inc
Sale
34,998
75.03
2,625,899
2007-09-10
ALXN
Alexion Pharmaceuticals Inc
Sale
209
65.31
13,649
2007-07-25
ALXN
Alexion Pharmaceuticals Inc
Option Exercise
25,000
10.00
249,874
2007-07-25
ALXN
Alexion Pharmaceuticals Inc
Sale
25,000
56.70
1,417,500
2007-06-01
ALXN
Alexion Pharmaceuticals Inc
Option Exercise
25,000
9.25
231,250
2007-06-01
ALXN
Alexion Pharmaceuticals Inc
Sale
25,000
48.50
1,212,500
2007-03-12
ALXN
Alexion Pharmaceuticals Inc
Sale
758
37.15
28,159
2006-02-15
ALXN
Alexion Pharmaceuticals Inc
Option Exercise
5,000
10.50
52,500
2006-02-15
ALXN
Alexion Pharmaceuticals Inc
Sale
5,000
35.05
175,250
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Squinto Stephen P
(EVP & Head of Research & Devel of Alexion Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
